Asceneuron discovers and develops groundbreaking therapeutics for neurodegenerative disorders with high unmet medical needs: orphan tauopathies, Alzheimer’s and Parkinson’s diseases. A subsidiary of Merck KGaA.

Location

EPFL Innovation Park, 1015 Lausanne, Switzerland

Facts & figures
  • Type of organization

    Public company

  • Year of foundation

    2012

  • Number of employees in Switzerland

    1-9

Key business